![]() |
Medical Chief, Mood, Anxiety and Impulsivity Disorders Program, Douglas Institute
serge_dot_beaulieu_At_mcgill_dot_ca |
2005
Baptista T., De Mendoza S., Beaulieu S., Bermùdez A., Martinez M. (2005). Metabolic Syndrome during Atypical Anti-Psychotic Drug Treatment: Mechanisms and Management, Metabolic Syndrome and Related Disorders , 2 (4 ), 290-307.
Braehler C., Holowka D., Brunet A., Beaulieu S., Baptista T., Debruille J., Walker C., King S. (2005). Diurnal cortisol in schizophrenia patients with childhood trauma, Schizophr Res .
Yatham L. N., Kennedy S. H., O'Donovan C., Parikh S., Macqueen G., McIntyre R., Sharma V., Silverstone P., Alda M., Baruch P., Beaulieu S., Daigneault A., Milev R., Young L. T., Ravindran A., Schaffer A., Connolly M., Gorman C. P. (2005). Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies, Bipolar Disord , 7 Suppl 3 , 5-69.